Bibliography
- Pajno GB, Barberio G, De Luca F, et al. Prevention of new sensitization in asthmatic children monosentizes to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001;31:1392-7
- Eng PA, Reinhold M, Genhm HP. Long term efficacy preaesonal grass pollen immunotherapy in children. Allergy 2002;57:306-12
- Moller C, Dreborg Ferdousi HA, Halken S, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctativitis: the PAT study. J Allergy Clin Immunol 2002;109:251-6
- Eng PA, Boret-Reinhold M, Heijnen IA, Gnehm HP. Tweleve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood. Allergy 2006;61(2):198-201
- Moreno C, Cuesta-Herranz J, Farnade-Tavora L, Alvarez-Cuesta E. Immunotherapy safety: prospecitive multi-center, monitoring study of biologically standardized therapeutic vaccines for allergic diseases. Clin Exp Allergy 2004;34:527-31
- Kelso JM. The rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reactions. Ann Allergy Asthma Immunol 2004;92:235-7
- Roy SR, Sigmon JR, Olivier J, et al. Increased frequency of large local reactions among systematic reactors during subcutaneous allergen immunotherapy. Ann Allergy Asthma Immunol 2007;99(1):82-6
- Coop CA, Tankersiey MS. Dose adjustment practices among allergists for local reactions to immunotherapy. Ann Allergy Asthma Immunol 2007;99(1):77-81
- Mauro M, Russello M, Incorvaia C, et al. Comparison of efficacy, safety and immunologic effects of subcutaneus and sublingual immunotherapy in birch pollinosis: a randomized study. Eur Ann Alerg Clin Immunol 2007;39(4):119-22
- Cox L, Nelson H, Lockey R. Allergen immunotherapy: a practice parameter second update. J Allergy Clin Immunol 2007;120(suppl 3)
- Rank MA, Osilie CL, Krogman JL, et al. Alergen immunotherapy safety: characterizing systemie reactions and identifying risk factors. Allergy Asthma Proc 2008;29(4):400-5
- Norman PS. Immunotherapy: 1999-2004. J Allergy Clin Immunol 2004;113(6):1013-23
- Bousquet J, Hejjaoui A, Dhivert H, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Systemic reactions during the rush protocol in patients suffering from asthma. J Allergy Clin Immunol 1989;83;792-802
- Bernstein DI, Wanner M, Borish L, Liss GM. Immunotherapy Committee, American Academy of allergy, asthma and Immunology. J Allergy Clin Immunol 2004;113(6):1129-36
- Luderitz-Puchel U, Keller-Stanisawski B, HAustein D. Neubewertung des Risikos von Test-und Therapieallergenen. Gesundheitsforsch Gesundheitsschutz 2001;44:709-18
- Amin HS, Liss GM, Bernstein Dl. Evaluation of near-fatal reactions to allergen immunotherapy injections. J Allergy Clin Immunol 2006;117:169-75
- Ameal A, Vega-Chicote JM, Fernandez S. Double-blind and placebo controlled study to assessefficacy and safety of a modified allergen extract of Dermatophagoides pteronyssimus on allergic asthma. Allergy 2005;60:1179-83
- Muller U, Hari Y, Berchtold E. Premedication with antihistamines may enhance efficacy of specific allergen immunotherapy. J Allergy Clin Immunol 2001;107:81-6
- Ohashi Y, Nkai Y, Murata K. Effect of pretreatment with fexofenadine on the safety of immunotherapy in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2006;96:600-5
- Jutel M, Watanabe T, Klunker S, et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 2001;413(6854):420-5
- Casale TB, Busse WW, Kline JN, et al. Immune Tolerance Network Group: omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis. J Allergy Clin Immunol 2006;117:134-40
- Rogala B, Glück J. Allergen-specific IgE in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy. Invest Allergol Clin Immunol 1991;9(3):183-9
- Stock P, Rolinck-Werninghaus C, Wahan U, Hamelmann E. The role of anti-IgE therapy in combination with allergen specific immunotherapy for seasonal allergic rhinitis. Bio Drugs 2007;21(6):403-10
- Magnan A, Humbert M. Is deficient tolerance the true paradigm for atopic diseases? Clin Exp Allergy 2005;35:1507-10
- Pfaar O, Klimek L. Efficacy and safety of specific immunotherapy with a high-dose sublingual grass pollen preparation: a double-blind, placebo-controleed trial. Ann Allergy Asthma Immunol 2008;100(3):256-63
- Passalacqua G, Guerra L, Compalati E, Canonica GW. The safety of allergen specific sublingual immunotherapy. Curr Drug Saf 2007;2(2):117-23
- Cox L. Sublingual immunotherapy in pediatric allergic rhinitis and asthma: efficacy safety, and practical considerations. Curr Allergy Asthma Rep 2007;7(6):410-20
- Ibañez MD, Kaiser F, Knecht R, et al. Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children. Pediatr Allergy Immunol 2007;18(6):516-22
- Blazowski L. Anaphylactic shock because of sublingual immunotherapy overdose during third year of maintenance dose. Allergy 2008;63:374-81